Flow Cytometry Market Growth, Regional Analysis, Trends and Forecast by 2032

The global Flow Cytometry Market is expected to experience profitable growth at a 7.4% CAGR from 2022 to 2032. The global market is expected to reach a valuation of US$ 5.6 billion by the end of 2022 and nearly US$ 11.4 billion by the end of 2032. According to Future Market Insights’ reports on the flow cytometry market, reagents, consumables, and accessories are the market’s leading product, accounting for approximately 44.3% of the global market in 2021. Because of high-throughput quantitative analysis, advancements in in vivo flow cytometry, and assessments of minimal residual diseases, global flow cytometry is expected to become even more important in medicine.

Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5263

Flow cytometry demand is expected to surge, offsetting any industry margin compressions. By providing multiple molecular and cellular knowledge within a single cell, flow cytometry techniques provide impressive diagnostic opportunities in the majority of oncologic and hematologic diseases. The flow cytometry market includes some specific benchtop applications, particularly in haematology and oncology, as well as general limitations that have proven profitable for the said market.

Increasing healthcare spending and public awareness are expected to boost the flow cytometry market share. The FASCaliber flow cytometer has many applications, including cell sorting, immunophenotyping, intracellular calcium flux, and cell proliferation assays. This technique has several advantages, such as its ease of use, which are expected to increase its demand in the coming years. This method is increasingly used in clinical studies and research for all cytometry market participants, which has opened up a variety of new growth prospects all over the world.

Key Takeaways

• A growing number of immunoassay techniques are being developed at a rapid pace, including the Accuri flow cytometer, which is attributed to recombinant antibody technology. Recombinant antibodies are widely used in the development of more sophisticated panels that are priced competitively with flow cytometers.
• Monoclonal antibodies incorporate a stronger ability to detect subtle antigenic alterations and small targets such as epitope variants, post-translational modifications, and conformational changes by combining the high specificity and affinity of monoclonal antibodies with recombinant technology.
• Furthermore, nowadays it has become very common to change the flow cytometry region in order to avoid clashes with several other antibodies within a flow cytometry panel. By decreasing the high background which commonly takes place when antibodies bind to Fc receptors, recombinant antibodies have reduced the flow cytometry cost. As a result, varieties of market opportunities are now being established by the introduction of recombinant DNA technology for antibody production in flow cytometry.
• The development of monoclonal antibodies, fluorescence, and laser technology has managed to diversify by adding new options for developing the best flow cytometers to investigate intracellular compartments for the determination of cellular functionality. In addition to that, the expansion of business over digital distribution channels has proven to be groundbreaking development for several small flow cytometer manufacturers with a limited and dispersed customer base.

Ask the Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-5263

Competitive Landscape

Several key companies in the flow cytometry production sphere are witnessing fierce competition and the overall market is highly fragmented due to the presence of local and regional players in the market. In order to expand the consumer base and meet the demands of consumers, the prominent flow cytometry market players are implementing methods such as acquisitions and mergers, collaborations and partnerships, and new product launches.

More Insights into the Flow Cytometry Market

The US. is expected to dominate the North American flow cytometry market as it accounted for a total market share of around 92.0% in 2021 and is anticipated to continue to experience the same growth across the forecast period.

China is the second leading country dominating the East Asian flow cytometry market as it accounted for around 42.1% share in 2021 and is projected to display growth at a lucrative CAGR of 12.3% during the forecast period.

Key Segments

By Product Type:

• Flow Cytometer System
  • Tradition Flow Cytometer
    • Cell Sorters
    • Imaging Flow Cytometers
  • Acoustic Focusing Cytometers
  • Next Generation Flow Cytometers
  • Reagents, Consumables & Accessories
  • Software
  • Services

By Application:

• Immunophenotyping
• Cell Sorting
• Cell Cycle Analysis
  • Apoptosis
  • Cell Proliferation Assays
  • Intracellular Calcium Flux
• Detection & Sorting of Exosomes
• Others

By Usage:

• Research Use
• Clinical Diagnostics

By End User:

• Hospitals
• Diagnostic Laboratories
• Academic and Research Institute
• Biopharmaceutical Companies

Buy Now@ https://www.futuremarketinsights.com/checkout/5263

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs